Annamaria Del Franco
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy.
Journal: International journal of cardiology
Published: March 11, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.
Journal: Circulation. Heart failure
Published: February 24, 2026
Cardiovascular Morbidity and Mortality in Fabry Disease.
Journal: Circulation. Genomic and precision medicine
Published: February 06, 2026
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal Study.
Journal: European heart journal. Quality of care & clinical outcomes
Published: December 06, 2025
Patterns of Left Ventricular Remodeling and Outcomes in Fabry Disease.
Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
Published: November 17, 2025
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition.
Journal: International journal of cardiology
Published: November 04, 2025
Voice recognition as an innovative method to identify and monitor heart failure - a review.
Journal: Heart failure reviews
Published: October 31, 2025
Sex-specific prognostic thresholds of left ventricular hypertrophy in fabry disease.
Journal: European heart journal. Cardiovascular Imaging
Published: August 19, 2025
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World Data.
Journal: Current cardiology reports
Published: August 17, 2025
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
Journal: International journal of cardiology
Published: July 30, 2025
Eplerenone for Nonobstructive Hypertrophic Cardiomyopathy: The (T1)me Is Now?
Journal: JACC. Heart failure
Published: July 06, 2025
Hypercontractile phenotype in hypertrophic cardiomyopathy indicates unfavorable hemodynamics, coronary flow and prognosis.
Journal: European heart journal. Cardiovascular Imaging
Published: June 24, 2025
Last Updated: 09/26/2026